Moderna Vaccine Efficacy Will Be Known in the Fall: Bancel

June 25, 2020, 6:00 AM

The efficacy of Moderna’s vaccine against the novel coronavirus will be known in the fall, with a possible regulatory approval at the end of the year or in early 2021, CEO Stephane Bancel says in an interview on France 2 television.

  • Phase 3 trial to begin in July on 30,000 patients, with a result in the fall: Bancel
  • CEO says he remains confident that a vaccine will be developed against the virus, with an 80-90% chance it will be ready next year
    • “We’ve been lucky on a global level that this is a virus that isn’t that complicated biologically,” Bancel ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.